{"id":"W4399374116","doi":"10.1200/jco.2024.42.17_suppl.lba5","title":"ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Durvalumab; Oncology; Internal medicine; Stage (stratigraphy); Lung cancer; Cancer; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005625402,0.0004076231,0.0007514399,0.0001840171,0.0002088729,0.0003546087,0.0004831676,0.000392892,0.005547707],"category_scores_gemma":[0.0006204345,0.0001575671,0.0004008286,0.0002456797,0.000344724,0.0003703417,0.0002493034,0.0009234498,0.0005857035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004540654,"about_ca_system_score_gemma":0.0008568411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006325341,"about_ca_topic_score_gemma":0.002655406,"domain_scores_codex":[0.999785,0.0001045111,0.00001594444,0.00003655678,0.00001736032,0.00004054803],"domain_scores_gemma":[0.9996845,0.00005770168,0.00006417901,0.00002352325,0.00001346463,0.0001566079],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7240891,0.007893068,0.006023759,0.001024139,0.0007300274,0.0001347957,0.0000981281,0.0008600249,0.02090982,0.0004262194,0.004357937,0.2334531],"study_design_scores_gemma":[0.7067853,0.2465574,0.01981509,0.0001334195,0.001021699,0.0005038318,0.00006730421,0.001361474,0.007155091,0.0005093922,0.01606691,0.00002315845],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853927,0.005865539,0.0005875241,0.0007039732,0.0002140013,0.001809513,0.001291577,0.0001216954,0.004013399],"genre_scores_gemma":[0.9936505,0.001586891,0.0009188199,0.0004022285,0.00007343892,0.000884402,0.0006319418,0.000007899464,0.001843881],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005547707,"threshold_uncertainty_score":0.01855892,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1353677718552765,"score_gpt":0.522701672356838,"score_spread":0.3873339005015615,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}